Davide Gianni
Senior Director, AstraZeneca
Davide Gianni is listed as Senior Director, AstraZeneca. Davide is scheduled to speak at SLAS 2027 International Conference & Exhibition on 30 January 2027.
Compiled from published conference agendas; not yet confirmed by Davide. Is this you? Claim this profile.
About
Dr. Davide Gianni is Senior Director Functional Genomics in Discovery Sciences, BioPharmaceuticals R&D at AstraZeneca and is responsible for leading a department comprising of scientists whose aim is to deliver new therapeutic opportunities for Astrazeneca’s therapy areas of interest. Davide joined AZ from Boehringer-Ingelheim in 2015 where, acting as a Research Laboratory Head, he has led a team of scientists aimed at discovering novel target opportunities for Oncology. Davide has authored >25 publications and has co-edited the first dedicated Special Issue on Functional Genomics for SLAS Discovery journal. He has played a key role in initiating the partnership with MRC and University of Cambridge for the creation of the Functional Genomics Screening Laboratory (FGSL). He is a member on the MRC advisory board for the UK Functional Genomics Initiative, a JMC member for the Joint AZ/CRUK Functional Genomics Centre and now a member of the JSC for the FGSL.
Upcoming
SLAS 2027 International Conference & Exhibition 30 January 2027 – 3 February 2027
- Genome Editing and AI-Driven Approaches in Drug Discovery and Target Validation Speaker · 30 January 2027
Spoke alongside
People who have shared a session with Davide at events on B2DB.
- Sam Hasson Senior Director, Target Biology · Rgenta Therapeutics 1 shared session
- Scott Younger Director, Disease Gene Engineering · Children’s Mercy Research Institute 1 shared session